secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2021-12-16T23:59:59+00:00
Accession:  0001564590-21-060502
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics appoints Nicole Onetto to board; Ashish Khanna resigns
---------------------------------------------------------------------------

- Ashish Khanna resigned from Bolt board and its Audit and Compensation committees effective Dec 13, 2021; no disagreement.
- Nicole Onetto appointed as Class III director effective Dec 14, 2021; term expires at 2024 annual meeting.
- Dr. Onetto received initial option grant of 27,860 shares vesting over 36 months and annual grant of 13,930 shares.
- She also receives $35,000 annual cash retainer and standard indemnification; Board determined she is independent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/0001564590-21-060502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/bolt-8k_20211213.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-060502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer